A prior study by our group in the late 90s showing that the administration of ovalbumin-specific Tr1 cells, together with their cognate antigen, reduced atherosclerosis in Apoe−/− mice was the first demonstration that manipulation of Tregs is a promising anti-atherosclerotic strategy. This evidence concerns the gene APOE and atherosclerosis.